Novel Emapalumab-Containing Regimen for Treatment of Indeterminate Severe Hepatitis in the Setting of T-Cell–Mediated Immune Dysregulation
Benjamin L. Shneider, MD, FAASLD
, Abstract Presenter
Pediatrics
11:15 AM
- 11:30 AM
Aug
06
2026
Convention Center - Room 146C, Level 1
Induction of Exhaustion Pathways Defines the Immune Microenvironment and Predicts Survival with Native Liver in Pediatric Acute Liver Failure
Emily R Perito, MD, MAS
, Abstract Presenter
Pediatrics
11:30 AM
- 11:45 AM
Aug
06
2026
Convention Center - Room 146C, Level 1
Etiology of Pediatric Acute Liver Failure in Patients Screened for the Treatment for Immune Mediated Pathophysiology (TRIUMPH) Trial
Samar H Ibrahim, MBCHB, FAASLD
, Abstract Presenter
Pediatrics
11:45 AM
- 12:00 PM
Aug
06
2026
Convention Center - Room 146C, Level 1
Bystander Activation of Cytotoxic CD8 T Cells as a Mechanism for Indeterminate Pediatric Acute Liver Failure
Benjamin L. Shneider, MD, FAASLD
, Abstract Presenter
Pediatrics
12:00 PM
- 12:15 PM
Aug
06
2026
Convention Center - Room 146C, Level 1
Epitope Mismatch Successfully Identifies Pediatric Liver Transplant Recipients At Risk for Late T-cell Mediated Rejection
Emily R Perito, MD, MAS
, Abstract Presenter
Pediatrics
12:15 PM
- 12:30 PM
Aug
06
2026
Convention Center - Room 146C, Level 1
Outcomes After Pediatric First Variceal Hemorrhage – Results from 44 Centers Participating in the International Multicenter Pediatric Portal Hypertension Registry (IMPPHR)
Benjamin L. Shneider, MD, FAASLD
, Abstract Presenter
Pediatrics
Objectives
Discuss pediatric transplant listing concerns
Explore new understandings of specific inflammatory pathways in PALF
Describe ways in which pediatric consortia can help provide novel information to improve clinical care